Shield Therapeutics - Approval for ACCRUFeR in China expected in Q1 2026
RNS
Latest announcements
Announcement summary
Shield Therapeutics - Approval for ACCRUFeR in China expected in Q1 2026
Filing for Approval for ACCRUFeR in China expected in Q1 2026
Ask a question
Your question will be visible to everyone.
Investor Q&As
Start the conversation
Ask Shield Therapeutics a question about this announcement.